A bromodomain inhibitors inhibit amoeboid movement in diffuse large B cell lymphoma
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 107 === Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell malignant tumor which is occasionally detected in middle-aged lymphoma patient. The main characteristic of DLBCL dissemination being observed constantly is the skip metastasis, which is different...
Main Authors: | Sung-Lin Chen, 陳松霖 |
---|---|
Other Authors: | Muh-Hwa Yang |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/67uq24 |
Similar Items
-
STAT3 facilitates amoeboid movement in diffuse large B-cell lymphoma
by: Yu-Tien Chan, et al.
Published: (2017) -
Studies in Dictyostelium discoideum on the role of membranes in amoeboid cell movement
by: Clotworthy, Margaret
Published: (2006) -
Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells
by: Angela Leo, et al.
Published: (2021-07-01) -
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
by: Etienne Leveille, et al.
Published: (2021-04-01) -
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
by: Sergey Karakashev, et al.
Published: (2017-12-01)